Flow-cytometric analysis revealed substantial IL1RL1 expression from most AML patients, while samples from healthy donors were expressing this receptor at very low levels (Figures 1A, B and Supplemental Figure S1). The gene discussed is IL1RL1; the disease is acute myeloid leukemia.